Wegovy vs Mounjaro: Mechanism, Dosing & UK Availability
What Is The Difference Between Wegovy And Mounjaro: Core Mechanisms
Understanding what is the difference between wegovy and mounjaro starts with their distinct biological mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro utilises tirzepatide, a dual agonist targeting both GIP and GLP-1 receptors, potentially offering broader metabolic effects through its two-pathway approach.
Both prescription-only medicines work alongside a reduced-calorie diet and increased physical activity to support weight management in adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. When comparing what is the difference between wegovy and mounjaro, the mechanism distinction influences how each medication may affect your individual response. EverydayMeds provides both options through our GPhC-registered service (#9012878), allowing your prescriber to recommend the most suitable treatment based on your clinical assessment.
Pricing Comparison: Wegovy vs Mounjaro UK Online Costs
Cost considerations form a crucial part of understanding what is the difference between wegovy and mounjaro for UK patients. Wegovy pricing at EverydayMeds starts with our 0.25mg starter dose at £79.99 (after FIRST40 discount code), progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99) to the 2.4mg maintenance dose (£209.99). Our bundle options provide convenient multi-month supplies, such as the Intro Trio covering your first three dose escalations for £299.99.
Mounjaro follows a different pricing structure with its own dose escalation schedule and cost profile. When evaluating what is the difference between wegovy and mounjaro financially, consider the total treatment journey rather than individual pen costs. Both medications require prescription-only dispensing through our clinical assessment process, with new customers applying code FIRST40 and returning customers using DOSE25 at checkout to access our competitive pricing across the UK market.
Clinical Evidence: STEP Trials vs SURMOUNT Studies
Research data highlights important aspects of what is the difference between wegovy and mounjaro in clinical outcomes. In the STEP clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent results across different patient populations, including those with type 2 diabetes.
Mounjaro's SURMOUNT trials evaluated tirzepatide's dual-agonist approach in weight management contexts. When considering what is the difference between wegovy and mounjaro clinically, both medications showed substantial efficacy in their respective trial programmes. Individual results may vary, and both treatments require ongoing commitment to dietary and lifestyle modifications for optimal outcomes within UK clinical practice.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy's semaglutide activates GLP-1 receptors throughout your body, particularly in the brain's appetite control centres and digestive system. This activation slows gastric emptying, meaning food stays in your stomach longer and promotes feeling full after smaller portions. The medication also influences hypothalamic appetite regulation, potentially reducing food cravings and the psychological drive to eat. Weekly injections maintain steady semaglutide levels, providing consistent appetite suppression throughout your treatment journey. Understanding this mechanism helps clarify what is the difference between wegovy and mounjaro at the cellular level, as Wegovy's focused GLP-1 action differs from dual-pathway approaches.
Simple Online Ordering Process For Both Treatments
Accessing either treatment when researching what is the difference between wegovy and mounjaro requires identical steps through EverydayMeds' streamlined process. Complete our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers review your submission within 3 working days (or 24 hours with express service), determining suitability and recommending the most appropriate option. Once approved, your genuine medication dispatches via next-day cold-chain delivery, maintaining proper temperature control throughout transit. This unified approach means you can explore what is the difference between wegovy and mounjaro without navigating separate ordering systems or clinical pathways.
Storage Requirements: Practical Daily Considerations
Storage differences represent a key practical element of what is the difference between wegovy and mounjaro for UK users. Wegovy pens require refrigeration at 2-8°C before first use but tolerate up to 6 weeks at room temperature below 30°C once removed from the fridge. Mounjaro allows only 21 days at room temperature after refrigeration, requiring more careful planning for travel or daily storage. Both medications use similar injection pen systems, though Wegovy employs Novo Nordisk's FlexTouch technology with dose escalation from 0.25mg through to 2.4mg maintenance. The extended room temperature tolerance makes Wegovy particularly suitable for frequent travellers or those preferring flexible storage options. This practical consideration often influences patient preference when evaluating what is the difference between wegovy and mounjaro for long-term use.
UK-Specific Prescribing Considerations: MHRA vs MHRA Approvals
Regulatory differences form another aspect of what is the difference between wegovy and mounjaro within UK healthcare. Wegovy received MHRA approval for weight management with specific BMI criteria and forms part of NICE guidance TA875 for specialist weight management support. The medication carries additional monitoring status (Black Triangle ▼) as a relatively recent approval requiring enhanced safety surveillance. Both treatments require specialist prescriber assessment to ensure appropriate patient selection and ongoing monitoring compliance.
When UK patients research what is the difference between wegovy and mounjaro, regulatory approval timing and specific licensed indications may differ between treatments. EverydayMeds ensures all prescribing follows current MHRA guidance and professional pharmacy standards. Our clinical team stays updated with evolving regulations and prescribing recommendations, providing patients with current information about both treatment options through our GPhC-registered service.
Make Your Treatment Decision With Expert Support
Determining what is the difference between wegovy and mounjaro ultimately depends on individual clinical factors, lifestyle preferences, and treatment goals that our prescribers assess during consultation. Both treatments are available through EverydayMeds with identical ordering processes, clinical oversight, and delivery standards. New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25 to access our competitive UK pricing. Start your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to receive expert guidance on which treatment aligns with your weight management journey. Our qualified prescribers provide personalised recommendations based on your medical history, ensuring you receive the most appropriate prescription-only medicine for your individual circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
